Search results for " Dose"

showing 10 items of 593 documents

The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids

2017

Objective: The aim of this study was to prospectively assess the efficacy and safety of low doses of sublingual fentanyl (SLF) for the treatment of breakthrough pain (BTP) in cancer patients in patients who were receiving low opioid doses for background analgesia. Methods: A sample of cancer patients presenting BTP episodes and receiving stable low doses of opioids for background pain (less than 60 mg of oral morphine equivalents) was selected to assess the efficacy and safety of low doses of SLF (67 μg). For each patient, data from four consecutive episodes were collected. For each episode, changes in pain intensity and adverse effects when pain got severe (T0), and 5, 10, and 15 min a…

MaleBreakthrough-episodic pain; Cancer pain; Opioids; Sublingual tablet; OncologyBreakthrough PainPain medicineAdministration SublingualOpioidFentanyl03 medical and health sciences0302 clinical medicineBreakthrough-episodic painmedicineHumansIn patientProspective StudiesCancer painProspective cohort studySublingual tabletAgedbusiness.industryLow doseBreakthrough PainOpioidsAnalgesics OpioidFentanylProspective StudieOpioidOncology030220 oncology & carcinogenesisAnesthesiaFemaleCancer painbusiness030217 neurology & neurosurgerymedicine.drugHuman
researchProduct

Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controll…

2006

To evaluate the efficacy and tolerability of a novel hydrofluoroalkane (HFA) pressurised metered dose inhaler (pMDI) formulation of budesonide (Pulmicort) versus the conventional chlorofluorocarbon (CFC) pMDI formulation in paediatric patients with asthma.This was a Phase III, multicentre, 12-week, double-blind, randomised, parallel-group study involving children (6-12 years of age) with mild to moderate asthma. Patients received either budesonide HFA pMDI or budesonide CFC pMDI 200 mug twice daily, with or without a spacer (NebuChamber/Nebunette). Primary efficacy endpoint: mean percentage change in forced expiratory volume in 1 second (FEV(1)) from baseline to week 12. Secondary efficacy …

MaleBudesonideVital capacityHydrocarbons FluorinatedPeak Expiratory Flow Ratelaw.inventionchemistry.chemical_compoundDouble-Blind MethodRandomized controlled triallawmedicineHumansMetered Dose InhalersBudesonideChildAsthmaChlorofluorocarbonbusiness.industryInhalerGeneral Medicinemedicine.diseaseMetered-dose inhalerAsthmaBronchodilator AgentsTreatment OutcomeAerosol PropellantschemistryTolerabilityAnesthesiaFemaleChlorofluorocarbonsbusinessmedicine.drugCurrent Medical Research and Opinion
researchProduct

The rat liver foci bioassay: II. Investigations on the dose-dependent induction of ATPase-deficient foci by vinyl chloride at very low doses

1985

In order to study the dose-dependence of the genotoxic effect of vinyl chloride (VC) hepatocellular ATPase-deficient foci were evaluated after subchronic exposure of newborn rats. Wistar rats were exposed from day 1 after birth over 10 weeks to 10, 40, 70, 150, 500 and 2000 p.p.m. VC (8 h/day; 5 days/week). One week after cessation of exposure hepatic ATPase-deficient foci were quantitated. For a subsequent investigation lower dose range groups of female and male Wistar and Sprague-Dawley rats were exposed (8 h/day; 5 days/week) to 2.5, 5, 10, 20, 40 and 80 p.p.m. VC. Exposure started at day 3 of life and lasted for 3 weeks. After cessation of exposure the animals were maintained for 10 wee…

MaleCancer ResearchPathologymedicine.medical_specialtyVinyl CompoundsATPaseVinyl ChlorideDose dependenceVinyl chlorideAndrologychemistry.chemical_compoundLiver Neoplasms ExperimentalSex FactorsSpecies SpecificitymedicineAnimalsBioassayCarcinogenAdenosine TriphosphatasesDose-Response Relationship DrugbiologyLow doseRats Inbred StrainsGeneral MedicineRatsLinear relationshipLiverchemistryRat liverbiology.proteinBiological AssayFemalePrecancerous ConditionsCarcinogenesis
researchProduct

Reduced-dose computed tomography is the most accurate method to measure ceramic hip resurfacing cup version

2020

Background: A precise assessment of cup version after hip resurfacing is generally requested, especially in clinical trials or in case of complications. Aims: To identify which diagnostic imaging modality, between AP pelvis X-rays, the AP Pelvis CT Scout image and reduced-dose axial CT scan, is the most precise to assess cup version of an all-ceramic hip resurfacing implant in a first-in-human clinical trial. Methods: We retrospectively assessed the cup version of the first 20 patients who underwent an experimental all-ceramic hip resurfacing on AP pelvis X-rays (0.8 mSv of radiation), AP pelvis CT scout images (0.016 mSv) and axial CT slices performed using a reduced dose protocol (0.3 mSv…

MaleCeramicsArthroplasty Replacement Hipmedicine.medical_treatmentReproducibility of ResultComputed tomographyCT scout viewRadiation DosageHip joint replacement030218 nuclear medicine & medical imaging03 medical and health sciencesCT/low dose0302 clinical medicineRetrospective StudieMedical imagingmedicineX-rays/radiographsHumansHip ProsthesiRadiology Nuclear Medicine and imagingPelvisRetrospective Studiesmedicine.diagnostic_testX-rays/radiographbusiness.industryReproducibility of ResultsGeneral MedicineMiddle AgedHip joint/cup versionCeramicReduced doseHip resurfacingHip joint/replacementRadiation exposureTomography x ray computedmedicine.anatomical_structure030220 oncology & carcinogenesisFemaleHip JointHip ProsthesisHip joint/resurfacingTomography X-Ray ComputedNuclear medicinebusinessHuman
researchProduct

Toxicity of 4-chloro-O-cresol to rat: I. Light microscopy and chemical observations.

1979

MaleChemistryHealth Toxicology and MutagenesisMusclesThin layerKidney pathologyGeneral MedicineOrgan SizeToxicologyKidneyPollutionMedian lethal doseRats4-chloro-o-cresolLethal Dose 50CresolsLiverToxicityMicroscopyEcotoxicologyAnimalsChromatography Thin LayerLiver pathologySpleenNuclear chemistryBulletin of environmental contamination and toxicology
researchProduct

A simple analytical method for heterogeneity corrections in low dose rate prostate brachytherapy

2015

In low energy brachytherapy, the presence of tissue heterogeneities contributes significantly to the discrepancies observed between treatment plan and delivered dose. In this work, we present a simplified analytical dose calculation algorithm for heterogeneous tissue. We compare it with Monte Carlo computations and assess its suitability for integration in clinical treatment planning systems. The algorithm, named as RayStretch, is based on the classic equivalent path length method and TG-43 reference data. Analytical and Monte Carlo dose calculations using Penelope2008 are compared for a benchmark case: a prostate patient with calcifications. The results show a remarkable agreement between …

MaleComputer sciencemedicine.medical_treatmentMonte Carlo methodBrachytherapyBrachytherapybrachytherapyDose calculation algorithmProstate:FÍSICA [UNESCO]medicineHumansRadiology Nuclear Medicine and imagingRadiation treatment planningprostateRadiological and Ultrasound Technologybusiness.industryRadiotherapy Planning Computer-AssistedUNESCO::FÍSICAProstatic NeoplasmsRadiotherapy Dosagelow dose rate:CIENCIAS MÉDICAS [UNESCO]medicine.anatomical_structurecalcificationsUNESCO::CIENCIAS MÉDICASBenchmark (computing)Nuclear medicinebusinessAlgorithmProstate brachytherapyAlgorithmsheterogeneities
researchProduct

Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.

2019

Background Results of recent phantom studies show that variation in CT acquisition parameters and reconstruction techniques may make radiomic features largely nonreproduceable and of limited use for prognostic clinical studies. Purpose To investigate the effect of CT radiation dose and reconstruction settings on the reproducibility of radiomic features, as well as to identify correction factors for mitigating these sources of variability. Materials and Methods This was a secondary analysis of a prospective study of metastatic liver lesions in patients who underwent staging with single-energy dual-source contrast material-enhanced staging CT between September 2011 and April 2012. Technique p…

MaleContrast MediaRadiation Dosage030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesCluster analysisNeoplasm StagingReproducibilitybusiness.industryRadiation doseLiver NeoplasmsReproducibility of ResultsReconstruction algorithmMiddle AgedHierarchical clusteringFeature (computer vision)radiomics030220 oncology & carcinogenesisRadiographic Image Interpretation Computer-AssistedFemaleTomographybusinessNuclear medicineTomography X-Ray ComputedCt reconstructionAlgorithmsRadiology
researchProduct

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.

2008

The aim of this study was to compare the analgesic and adverse effects, doses, as well as cost of opioid drugs, supportive drug therapy and other analgesic drugs in patients treated with oral sustained-release morphine, transdermal fentanyl, and oral methadone.One hundred and eight cancer patients, no longer responsive to opioids for moderate pain, were selected to randomly receive initial daily doses of 60 mg of oral sustained-release morphine, 15 mg of oral methadone, or 0.6 mg (25 microg/h) of transdermal fentanyl. Oral morphine was used as breakthrough pain medication during opioid titration. Opioid doses, pain intensity, adverse effects, symptomatic drugs, were recorded at week interva…

MaleCost-Benefit AnalysisAdministration OralFentanylNeoplasmscancer pain opioidsProspective StudiesCancer painTransdermalIntractableAnalgesicsMorphineMiddle AgedPain IntractableAnalgesics OpioidFentanylNeuropsychology and Physiological PsychologyTreatment OutcomeNeurologyPatient SatisfactionAnesthesiaAdministrationFemaleDrugmedicine.drugOralAdultAdolescentAnalgesicPainOpioidAdministration CutaneousDrug Administration ScheduleDose-Response RelationshipmedicineHumansAdverse effectAgedDose-Response Relationship Drugbusiness.industryCostsCutaneousAnesthesiology and Pain MedicineOpioidCancer pain; Costs; Fentanyl; Methadone; Morphine; Administration Cutaneous; Administration Oral; Adolescent; Adult; Aged; Analgesia; Analgesics Opioid; Cost-Benefit Analysis; Dose-Response Relationship Drug; Drug Administration Schedule; Female; Fentanyl; Humans; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain Intractable; Patient Satisfaction; Prospective Studies; Quality of Life; Treatment Outcome; Anesthesiology and Pain Medicine; Neurology; Neuropsychology and Physiological PsychologyMorphineQuality of LifeAnalgesiaCancer painbusinessMethadoneMethadoneEuropean journal of pain (London, England)
researchProduct

Reactogenicity and Immunogenicity at Preschool Age of a Booster Dose of Two Three-Component Diphtheria-Tetanus-Acellular Pertussis Vaccines in Childr…

2001

Objectives.To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-component acellular pertussis vaccines combined with diphtheria-tetanus-acellular pertussis (DTaP) when administered at preschool age to children primed in infancy with 3 doses of the same DTaP and who had received a diphtheria-tetanus (DT) dose at the age of 12 months.Setting.Local health units of 4 Italian regions.Study Design.Three thousand five hundred twenty-two children, who had been randomized in the first year of life to be immunized with a DTaP vaccine by either SmithKline Beecham or Chiron Biocine, were offered a booster of the same vaccine or, if refusing, a DT vaccine at the age of 5 to 6 y…

MaleDiphtheria-Tetanus VaccinePediatricsmedicine.medical_specialtyImmunization SecondaryBooster doseInjectionsmedicineHumansProspective StudiesChildAdverse effectDiphtheria-Tetanus-Pertussis VaccineDiphtheria-Tetanus-acellular Pertussis VaccinesBooster (rocketry)Reactogenicitybusiness.industryImmunogenicityItalyChild PreschoolPediatrics Perinatology and Child HealthPertussis vaccineFemalePertactinbusinessmedicine.drugPediatrics
researchProduct

Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

2008

Bupropion, administered alone or combined with nicotine, is presently used to treat nicotine dependence. Despite experimental evidence of the complex behavioral actions of this drug, there have been little data reported about its effects on social behavior. Our main aim was to investigate the effects of acute administration of bupropion, alone or plus nicotine, on social interaction in mice. OF1 group-housed male mice were confronted in a neutral cage with an anosmic opponent during a 10 minutes encounter. Time allocated to body care and digging was reduced by administration of bupropion (40 mg/kg) both when administered alone and with nicotine (1 and 0.5 mg/kg). The lowest dose of bupropio…

MaleDrugNicotinemedicine.drug_classmedia_common.quotation_subjectMedicine (miscellaneous)Male miceAnxietyPharmacologyAnxiolyticDrug Administration ScheduleNicotineMiceDopamine Uptake Inhibitorsmental disordersmedicineAnimalsSocial BehaviorNicotine dependenceBupropionmedia_commonPharmacologyBupropionBehavior AnimalLow doseTobacco Use Disordermedicine.diseaseGanglionic StimulantsAggressionPsychiatry and Mental healthExploratory BehaviorPsychologymedicine.drugAddiction Biology
researchProduct